Cargando…

Micro-ultrasound Versus Magnetic Resonance Imaging in Prostate Cancer Active Surveillance

Accurate assessment of tumor grade is critical for active surveillance (AS) in prostate cancer. We compared magnetic resonance imaging (MRI) and micro-ultrasound scoring (Prostate Imaging-Reporting and Data System [PI-RADS] v2.1 vs Prostate Risk Identification using Micro-ultrasound [PRI-MUS]) in 12...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albers, Patrick, Wang, Betty, Broomfield, Stacey, Medina Martín, Anaïs, Fung, Christopher, Kinnaird, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Brief Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618766/ https://www.ncbi.nlm.nih.gov/pubmed/36325366 http://dx.doi.org/10.1016/j.euros.2022.09.019

Ejemplares similares

Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
por: Mookerji, Nikhile, et al.
Publicado: (2023)

Use of 29-MHz Micro-ultrasound for Local Staging of Prostate Cancer in Patients Scheduled for Radical Prostatectomy: A Feasibility Study
por: Regis, Federica, et al.
Publicado: (2020)

A Machine Learning Framework Reduces the Manual Workload for Systematic Reviews of the Diagnostic Performance of Prostate Magnetic Resonance Imaging
por: Nedelcu, Andrea, et al.
Publicado: (2023)

Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy
por: Manceau, Cécile, et al.
Publicado: (2020)

Using a Recurrent Neural Network To Inform the Use of Prostate-specific Antigen (PSA) and PSA Density for Dynamic Monitoring of the Risk of Prostate Cancer Progression on Active Surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2023)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
por: Tzeng, Michael, et al.
Publicado: (2021)

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
por: Ma, Chaoran, et al.
Publicado: (2023)

Role of prostate magnetic resonance imaging in active surveillance
por: Meng, Xiaosong, et al.
Publicado: (2017)

The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
por: Shaw, Greg L., et al.
Publicado: (2016)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
por: Scuderi, Simone, et al.
Publicado: (2023)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
por: An, Julie Y., et al.
Publicado: (2017)

The role of magnetic resonance imaging in active surveillance of prostate cancer
por: Alagbe, Olayemi Atinuke, et al.
Publicado: (2021)

Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses
por: Pratsinis, Manolis, et al.
Publicado: (2022)

Prostate Cancer Risk by BRCA2 Genomic Regions
por: Nyberg, Tommy, et al.
Publicado: (2020)

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
por: Turco, Fabio, et al.
Publicado: (2022)

Role of Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy and Transrectal Ultrasound in Evaluation of Prostatic Pathologies with Focus on Prostate Cancer
por: Lahoti, Amol Madanlal, et al.
Publicado: (2017)

Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation
por: Singh, Zorawar, et al.
Publicado: (2022)

Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [(177)Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer
por: Stangl-Kremser, Judith, et al.
Publicado: (2021)

Comparison of multiparametric ultrasound versus multiparametric magnetic resonance imaging for diagnosis of carcinoma prostate: The CADMUS trial
por: Tarigopula, Vivek
Publicado: (2022)

Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate
por: Hutten, Ryan J., et al.
Publicado: (2021)

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
por: Ullrich, T., et al.
Publicado: (2020)

Mobile PSA: A Novel Telehealth Tool for Prostate Cancer Follow-Up
por: Bergroth, Robin, et al.
Publicado: (2021)

Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer
por: Hougen, Helen Y., et al.
Publicado: (2023)

What can cardiac magnetic resonance do for cardiologists in China?
por: Xia, Rui, et al.
Publicado: (2013)

Magnetic resonance imaging-based pathogenic investigation of patellar instability
por: Song, Yi-Fan, et al.
Publicado: (2019)

A Novel Magnetic Resonance Rectography for Rectal Cancer Staging
por: Tang, Xue, et al.
Publicado: (2018)

Vertebral bone quality different in magnetic resonance imaging parameters
por: Liu, Xiang-Ge, et al.
Publicado: (2023)

Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological Outcomes
por: Qaoud, Yazan, et al.
Publicado: (2020)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
por: Fallara, Giuseppe, et al.
Publicado: (2023)

Diagnosis and Management of an Adenomatoid Uterine Tumor: Ultrasound, Magnetic Resonance Imaging, Surgical Appearance, and Pathology Correlation
por: Orlando, Jennie, et al.
Publicado: (2018)

Implications of the European Association of Urology Recommended Risk Assessment Algorithm for Early Prostate Cancer Detection
por: Israël, Bas, et al.
Publicado: (2022)

Transrectal ultrasound-guided prostate biopsy versus combined magnetic resonance imaging-ultrasound fusion and systematic biopsy for prostate cancer detection in routine clinical practice
por: Bae, Jae Heung, et al.
Publicado: (2020)

Leveraging Social Media as a Thermometer to Gauge Patient and Caregiver Concerns: COVID-19 and Prostate Cancer
por: Loeb, Stacy, et al.
Publicado: (2021)

Overexpression of Placental Growth Factor in Stromal Cells from Benign Prostatic Hyperplasia: Another Piece in the Puzzle?
por: Devlin, Conor M., et al.
Publicado: (2020)

Magnetic resonance spectroscopy findings of central pontine myelinolysis in an alcohol abuser
por: Shen, Yao-Yao, et al.
Publicado: (2020)

Magnetic Resonance Imaging in the Diagnosis of Mycetoma with Equivocal Clinical and Laboratory Features
por: Tarafdar, Swarnava, et al.
Publicado: (2022)

In-depth Analysis of the 2019 Advanced Prostate Cancer Consensus Conference: The Importance of Representation of Medical Specialty and Geographic Regions
por: Pratsinis, Manolis, et al.
Publicado: (2021)

Oligometastasis in Prostate Cancer: Can We Learn from Those “Excluded” from a Phase 2 Trial?
por: Glicksman, Rachel M., et al.
Publicado: (2023)

How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration
por: Májek, Ondřej, et al.
Publicado: (2023)

External Validation of a Prediction Model for Side-specific Extraprostatic Extension of Prostate Cancer at Robot-assisted Radical Prostatectomy
por: Veerman, Hans, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_05ove7627acgus2a87hnb0i8iv